Compare RGR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGR | YDES |
|---|---|---|
| Founded | 1949 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 677.2M | 543.0M |
| IPO Year | 1994 | N/A |
| Metric | RGR | YDES |
|---|---|---|
| Price | $40.02 | $4.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $43.00 | N/A |
| AVG Volume (30 Days) | ★ 105.7K | 4.9K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $546,057,000.00 | N/A |
| Revenue This Year | $2.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3,938.00 | ★ N/A |
| Revenue Growth | ★ 1.94 | N/A |
| 52 Week Low | $28.33 | $4.37 |
| 52 Week High | $48.21 | $25.00 |
| Indicator | RGR | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 36.94 |
| Support Level | $36.28 | $4.73 |
| Resistance Level | $44.44 | $5.36 |
| Average True Range (ATR) | 1.38 | 0.23 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 64.85 | 38.02 |
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.